Lv11
60 积分 2024-03-12 加入
High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials
10天前
已完结
Management of Patients with Ulcerative Proctitis: A Global Survey
13天前
已完结
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
14天前
已完结
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
15天前
已关闭
Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite
16天前
已关闭
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
18天前
已完结
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
19天前
已完结
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
19天前
已完结
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
19天前
已完结
The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases
25天前
已完结
皖公网安备34019202002308
